Michelle F. Correa
Diadema, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Therapeutic potential of LINS01 histamine H3 receptor antagonists as antineoplastic agents for triple negative breast cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 10, 2024
Neurotoxicity Assessment of 1-[(2,3-Dihydro-1-Benzofuran-2-yl)Methyl]Piperazine (LINS01 Series) Derivatives and their Protective Effect on Cocaine-Induced Neurotoxicity Model in SH-SY5Y Cell Culture.
Journal: Neurotoxicity research
Published: July 26, 2022
Evaluation of the histamine H3 receptor antagonists from LINS01 series as cholinesterases inhibitors: Enzymatic and modeling studies.
Journal: Chemical biology & drug design
Published: May 20, 2022
Novel potent (dihydro)benzofuranyl piperazines as human histamine receptor ligands - Functional characterization and modeling studies on H3 and H4 receptors.
Journal: Bioorganic & medicinal chemistry
Published: November 05, 2020
Assessment of the Physicochemical Properties and Stability for Pharmacokinetic Prediction of Pyrazinoic Acid Derivatives.
Journal: Current drug metabolism
Published: February 17, 2020
Novel potent vasodilating agents: Evaluation of the activity and potency of LINS01005 and derivatives in rat aorta.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: September 18, 2019
Differential contribution of H3R antagonism by LINS01 compounds on memory, anxiety-like behaviour and spontaneous locomotor activity in healthy rats.
Journal: Behavioural brain research
Published: May 30, 2019
Pharmacological and SAR analysis of the LINS01 compounds at the human histamine H1 , H2 , and H3 receptors.
Journal: Chemical biology & drug design
Published: March 01, 2018
Pharmacological Characterization of 5-Substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: Novel Antagonists for the Histamine H3 and H4 Receptors with Anti-inflammatory Potential.
Journal: Frontiers in pharmacology
Published: September 29, 2017
QSAR Modeling of Histamine H3R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases.
Journal: Current neuropharmacology
Published: January 25, 2017
1-[(2,3-Dihydro-1-benzofuran-2-yl) methyl]piperazines as novel anti-inflammatory compounds: Synthesis and evaluation on H3 R/H4 R.
Journal: Chemical biology & drug design
Published: October 22, 2016
Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: June 16, 2015
Last Updated: 09/26/2026